Finance

Lists
Why is XGN up 3,76%?
Dive Deeper
XGN:NASDAQ
Exagen Inc
8,56 $
+3,76%
(+0,31) 1D
13 қаз., 12:53:12 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XGN...
Open
8,18 $
High
8,63 $
Low
8,13 $
Mkt. cap
207,37 млн
Avg. vol.
280,33 м.
Volume
184,12 м.
52-wk high
12,23 $
52-wk low
2,60 $
EPS
-0,81 $
Beta
2,12
Shares outstanding
24,22 млн
No. of employees
218
Open
8,18 $
High
8,63 $
Low
8,13 $
Mkt. cap
207,37 млн
Avg. vol.
280,33 м.
Volume
184,12 м.
52-wk high
12,23 $
52-wk low
2,60 $
EPS
-0,81 $
Beta
2,12
Shares outstanding
24,22 млн
No. of employees
218
News stories
From web sources and news partners
About Exagen Inc
CEO-
Employees218
Founded2002
HeadquartersVista, Калифорния, Америка Құрама Штаттары
Sector-
Websiteexagen.com
Analyst ratings
Based on 5 analysts giving stock ratings to XGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for XGN in the last 3 months.
Highest
Current 8,56 $
12,00 $ (+40,19%)
Average
10,40 $ (+21,50%)
Lowest
9,00 $ (+5,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Brennan
TD Cowen
Buy
Maintained
11,00 $
+28,5%
10/13/2026
Max Masucci
Roth MKM
Buy
Maintained
11,00 $
+28,5%
09/22/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
12,00 $
+40,2%
09/11/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
12,00 $
+40,2%
08/05/2026
Mark Massaro
BTIG
Buy
Reiterated
9,00 $
+5,1%
08/05/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
9,00 $
+5,1%
08/05/2026
Unknown Analyst
Roth MKM
Buy
Initiated
8,00 $
-6,5%
06/24/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/12/2026
William Bonello
Craig-Hallum
Buy
Reiterated
10,00 $
+16,8%
03/11/2026
Paul Knight
KeyBanc
Buy
Maintained
10,00 $
+16,8%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
17,24 млн
16,63 млн
17,31 млн
19,94 млн
Cost of goods sold
7,17 млн
7,42 млн
7,10 млн
7,72 млн
Cost of revenue
7,17 млн
7,42 млн
7,10 млн
7,72 млн
Research and development expenses
1,73 млн
1,76 млн
1,55 млн
1,43 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,44 млн
12,42 млн
12,07 млн
12,51 млн
Operating expense
13,18 млн
14,18 млн
13,62 млн
13,94 млн
Total operating expenses
20,34 млн
21,61 млн
20,72 млн
21,66 млн
Operating income
-3,10 млн
-4,98 млн
-3,41 млн
-1,72 млн
Other non operating income
-
-
-132,00 м.
153,00 м.
EBT including unusual items
-7,09 млн
-4,66 млн
-3,93 млн
-3,20 млн
EBT excluding unusual items
-4,42 млн
-6,26 млн
-4,81 млн
-2,77 млн
Income tax expense
1,00 мың
13,00 мың
36,00 мың
-
Effective tax rate
-0,01%
-0,28%
-0,92%
-
Other operating expenses
-
-
-
-
Net income
-7,09 млн
-4,67 млн
-3,97 млн
-3,20 млн
Net profit margin
-41,10%
-28,10%
-22,92%
-16,03%
Earnings per share
-0,31
-0,27
-0,20
-0,11
Interest and investment income
3,00 мың
43,00 мың
-
-
Interest expense
-1,32 млн
-1,33 млн
-1,27 млн
-1,20 млн
Net interest expenses
-1,32 млн
-1,29 млн
-1,27 млн
-1,20 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,49 млн
-4,38 млн
-2,82 млн
-1,09 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары